Holistic Analytics Improves the Clinical Trials Selection Process at Hollings Cancer Center

References

• Alban A, Chick S, Forster M (2023) Value-based clinical trials: Selecting recruitment rates and trial lengths in different regulatory contexts. Management Sci. 69(6):3516–3535.Link, Google Scholar
• Bastani H, Drakopoulos K, Gupta V, Vlachogiannis J, Hadjichristodoulou C, Lagiou P, Tsiodras S (2022) Interpretable operations research for high-stakes decisions: Designing the Greek COVID-19 testing system. INFORMS J. Appl. Analytics 52(5):398–411.Link, Google Scholar
• Bennett CS, Ramsey SD, McDermott CL, Carlson JJ, Basu A, Veenstra DL (2015) Predicting low accrual in the national cancer institute’s cooperative group clinical trials. J. Natl. Cancer Inst. 108(2):djv324.Google Scholar
• Bennette CS, Veenstra DL, Basu A, Baker L, Ramsey SD, Carlson JJ (2016) Development and evaluation of an approach to using value of information analyses for real-time prioritization decisions within SWOG, a large cancer clinical trials cooperative group. Medical Decision Making 36(6):641–651.Google Scholar
• Bertsimas D, O’Hair A, Relyea S, Silberholz J (2016) An analytics approach to designing combination chemotherapy regimens for cancer. Management Sci. 62(5):1511–1531.Link, Google Scholar
• Bertsimas D, Li M, Liu X, Xu J, Khan N (2023) Data-driven COVID-19 vaccine development for Janssen. INFORMS J. Appl. Analytics 53(1):70–84.Link, Google Scholar
• Byrum J, Davis C, Doonan G, Doubler T, Foster D, Luzzi B, Mowers R, et al. (2016) Advanced analytics for agricultural product development. Interfaces (Providence) 46(1):5–17.Link, Google Scholar
• Carlson JJ, Kim DD, Guzauskas GF, Bennette CS, Veenstra DL, Basu A, Hendrix N, Hershman DL, Baker L, Ramsey SD (2018) Integrating value of research into NCI clinical trials cooperative group research review and prioritization: A pilot study. Cancer Medicine 7(9):4251–4260.Google Scholar
• Chaturvedi P, Singh A (2020) Clinical trials during COVID-19. Wiley Public Health Emergency Collect. 2(10):1516–1518.Google Scholar
• Chick S, Gans N, Yapar O (2022) Bayesian sequential learning for clinical trials of multiple correlated medical interventions. Management Sci. 68(7):4919–4938.Link, Google Scholar
• Davis SJ, Edwards SB, Teper GE, Bassett DG, McCarthy MJ, Johnson SC, Lawton CR, et al. (2016) Maximizing the U.S. army’s future contribution to global security using the capability portfolio analysis tool (CPAT). Interfaces (Providence) 46(1):91–108.Link, Google Scholar
• Esmail LC, Roth J, Rangarao S, Carlson JJ, Thariani R, Ramsey SD, Veenstra DL, Deverka PA (2013) Getting our priorities straight: A novel framework for stakeholder-informed prioritization of cancer genomics research. Genetics Medicine 15(2):115–122.Google Scholar
• Gouglas D, Hoyt K, Peacocke E, Kaloudis A, Ottersen T, Røttingen J-A (2019) Setting strategic objectives for the coalition for epidemic preparedness innovations: An exploratory decision analysis process. INFORMS J. Appl. Analytics 49(6):430–446.Link, Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 42(2):377–381.Google Scholar
• Heymach SG (2017) An analysis of factors affecting successful clinical trial enrollment in the context of three prospective randomized control trials. Int. J. Radiation Oncology Biol. Phys. 97(4):770–777.Google Scholar
• Kawamoto K, Houlihan CA, Balas EA, Lobach DF (2005) Improving clinical practice using clinical decision support systems: A systematic review of trials to identify features critical to success. BMJ 330(7494):765–768.Google Scholar
• Kik D, Wichmann M, Spengler T (2023) Small- or medium-sized enterprise uses operations research to select and develop its headquarters location. INFORMS J. Appl. Analytics 53(4):312–331.Link, Google Scholar
• Kouvelis P, Milner J, Tian Z (2017) Clinical trials for new drug development: Optimal investment and allocation. Manufacturing Service Oper. Management 19(3):437–452.Abstract, Google Scholar
• Kwan JL, Lo L, Ferguson J, Goldberg H, Diaz-Martinez JP, Tomlinson G, Grimshaw JM, Shojania KG (2020) Computerised clinical decision support systems and absolute improvements in care: Meta-analysis of controlled clinical trials. BMJ 370:m3216.Google Scholar
• Meyer MN, Gelinas L, Bierer BE, Hull SC, Joffe S, Magnus D, Mohapatra S, et al. (2021) An ethics framework for consolidating and prioritizing COVID-19 trials. Clinical Trials 18(2):226–233.Google Scholar
• MUSC - Hollings Cancer Center (2025) MUSC Hollings Cancer Center. Accessed October 25, 2025, https://hollingscancercenter.musc.edu/.Google Scholar
• Nipp RD, Hong K, Paskett ED (2019) Overcoming barriers to clinical trial enrollment. Amer. Soc. Clinical Oncology Educational Book 39:105–114.Google Scholar
• Reinig B, Horowitz I (2018) Using mathematical programming to select and seed teams for the NCAA tournament. Interfaces (Providence) 48(3):181–188.Link, Google Scholar
• Sateren WB, Trimble EL, Abrams J, Brawley O, Breen N, Ford L, McCabe M, et al. (2002) How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J. Clinical Oncology 20(8):2109–2117.Google Scholar
• Scheinker D, Brandeau M (2020) Implementing analytics projects in a hospital: Successes, failures, and opportunities. Interfaces (Providence) 50(3):176–189.Google Scholar
• Schroen AT, Petroni GR, Wang H, Thielen MJ, Gray R, Benedetti J, Slingluff CL (2012) Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. cooperative oncology groups. Clinical Cancer Res. 18(1):256–262.Google Scholar
• Siddiqi AE (2008) Early participant attrition from clinical trials: Role of trial design and logistics. Clinical Trials 5(4):328–335.Google Scholar
• Sinha I, Jones L, Smyth RL, Williamson PR (2008) A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Medicine 5(4):e96.Google Scholar
• Sygna K, Johansen S, Ruland CM (2015) Recruitment challenges in clinical research including cancer patients and caregivers. Trials 16(1):428.Google Scholar
• Thorlund K, Smith D, Linsell C, White N, Butler C, Boulware D, Currier J, et al. (2023) The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials. Comm. Medicine 3(1):53.Google Scholar
• Tian Z, Hazen G, Li H (2023) Optimal enrollment in late-stage new drug development with learning of drug’s efficacy for group-sequential clinical trials. Manufacturing Service Oper. Management 25(1):88–107.Link, Google Scholar
• Tran G, Harker M, Chiswell K, Unger JM, Fleury ME, Hirsch B, Miller K, d’Almada P, Tibbs S, Zafar SY (2020) Feasibility of cancer clinical trial enrollment goals based on cancer incidence. JCO Clinical Cancer Inform. 4:35–49.Google Scholar
• Unger JM, Cook E, Tai E, Bleyer A (2016) The role of clinical trial participation in cancer research: Barriers, evidence, and strategies. Amer. Soc. Clinical Oncology Educational Book 36:185–198.Google Scholar
• Yanga ZJ, McComas KA, Gay G, Leonard JP, Dannenberg AJ, Dillon H (2010) From information processing to behavioral intentions: Exploring cancer patients’ motivations for clinical trial enrollment. Patient Ed. Counseling 79(2):231–238.Google Scholar
• Zarepisheh M, Hong L, Zhou Y, Huang Q, Yang J, Jhanwar G, Deasy J (2022) Automated and clinically optimal treatment planning for cancer radiotherapy. INFORMS J. Appl. Analytics 52(1):69–89.Link, Google Scholar